Herb-induced hepatitis secondary to artemisinin: A case report

This report describes a rare case of severe liver injury secondary to a herbal supplement containing artemisinin. The patient received plasma exchange with bilirubin filtration adsorption therapy. The case is unique in its severe cholestasis. Bilirubin decreased to baseline after 62 days. This will...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Jiwei, Ding, Meilin, Li, Jin, Su, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583524/
https://www.ncbi.nlm.nih.gov/pubmed/36275804
http://dx.doi.org/10.3389/fmed.2022.1033906
_version_ 1784813089670037504
author Zhan, Jiwei
Ding, Meilin
Li, Jin
Su, Lei
author_facet Zhan, Jiwei
Ding, Meilin
Li, Jin
Su, Lei
author_sort Zhan, Jiwei
collection PubMed
description This report describes a rare case of severe liver injury secondary to a herbal supplement containing artemisinin. The patient received plasma exchange with bilirubin filtration adsorption therapy. The case is unique in its severe cholestasis. Bilirubin decreased to baseline after 62 days. This will help to improve clinicians' awareness of the diagnosis and treatment of drug-induced liver injury.
format Online
Article
Text
id pubmed-9583524
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95835242022-10-21 Herb-induced hepatitis secondary to artemisinin: A case report Zhan, Jiwei Ding, Meilin Li, Jin Su, Lei Front Med (Lausanne) Medicine This report describes a rare case of severe liver injury secondary to a herbal supplement containing artemisinin. The patient received plasma exchange with bilirubin filtration adsorption therapy. The case is unique in its severe cholestasis. Bilirubin decreased to baseline after 62 days. This will help to improve clinicians' awareness of the diagnosis and treatment of drug-induced liver injury. Frontiers Media S.A. 2022-10-06 /pmc/articles/PMC9583524/ /pubmed/36275804 http://dx.doi.org/10.3389/fmed.2022.1033906 Text en Copyright © 2022 Zhan, Ding, Li and Su. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Zhan, Jiwei
Ding, Meilin
Li, Jin
Su, Lei
Herb-induced hepatitis secondary to artemisinin: A case report
title Herb-induced hepatitis secondary to artemisinin: A case report
title_full Herb-induced hepatitis secondary to artemisinin: A case report
title_fullStr Herb-induced hepatitis secondary to artemisinin: A case report
title_full_unstemmed Herb-induced hepatitis secondary to artemisinin: A case report
title_short Herb-induced hepatitis secondary to artemisinin: A case report
title_sort herb-induced hepatitis secondary to artemisinin: a case report
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583524/
https://www.ncbi.nlm.nih.gov/pubmed/36275804
http://dx.doi.org/10.3389/fmed.2022.1033906
work_keys_str_mv AT zhanjiwei herbinducedhepatitissecondarytoartemisininacasereport
AT dingmeilin herbinducedhepatitissecondarytoartemisininacasereport
AT lijin herbinducedhepatitissecondarytoartemisininacasereport
AT sulei herbinducedhepatitissecondarytoartemisininacasereport

Ejemplares similares